UNSPSC 51283915: Sulfalene or sulfamethopyrazine

This classification denotes a sulfonamide anti-infective agent with the molecular formula C11H12N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier T6BL4ZC15G, chemically known as sulfanilamide, n(sup 1)-(3-methoxypyrazinyl)- but generally known as sulfalene, which bears US NIH Compound Identifier 9047. European Medicines Agency schedules Sulfalene in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10705MIG. The term SULFALENE is an International Non-Proprietary Name.

UNSPSC 51283915 Sulfalene or sulfamethopyrazine is a Commodity code that shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific veterinary antibiotic pharmaceutical, yet the recent opportunities posted under this code reflect procurement of naloxone, emergency medical supplies, generic pharmaceuticals and OTC products, and direct-to-manufacturer prescription programs — none of which are sulfalene or sulfamethopyrazine. The mismatch suggests either a data classification error in the source records or that this code is used inconsistently across state and local procurement systems to tag pharmaceutical acquisitions more broadly.

The issuing bodies tagging opportunities under this code span diverse government types: Seminole County, Florida (county health department); the City of Tampa (municipal fire rescue); the Texas Health and Human Services Commission (state health agency); and the Minnesota Department of Administration through the MMCAP cooperative purchasing program (multi-state alliance). Recent activity concentrates in Florida, Texas, and Minnesota, with the most concrete opportunity being the City of Tampa's March 2026 IFB for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, estimated at $700,000 and reserved for certified Small Local Business Enterprises with a 5% bid discount capped at $10,000. Seminole County issued IFB60459723LAS in June 2026 for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to its Community Health Building in Sanford, Florida. The Texas HHS Commission issued a Request for Information in April 2026 to explore direct-to-manufacturer prescription contracting models. The Minnesota MMCAP cooperative issued an RFP in January 2026 (response deadline March 26, 2026) for generic multi-source pharmaceuticals and OTC products across state and local government facilities in Minnesota and Oregon, requiring manufacturers to supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act standards. The code's sparse and off-target activity suggests limited current relevance to pursuit decisions.